USFDA for voluntary action by Cadila Healthcare on Ahmedabad SEZ facility

The plant has received an establishment inspection report (EIR). The EIR report stated that the classification of the facility is VAI, it added.

from Healthcare/Biotech-Industry-Economic Times http://bit.ly/2WHsoZ6
via IFTTT